<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04990973</url>
  </required_header>
  <id_info>
    <org_study_id>AAAT7042</org_study_id>
    <nct_id>NCT04990973</nct_id>
  </id_info>
  <brief_title>Evaluation of Diet and Sleep in Vascular Health</brief_title>
  <official_title>Influence of Diet on Sleep and Cardiovascular Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to test the impact of diet on sleep and cardiovascular disease risk&#xD;
      factors.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Poor sleep quality is highly prevalent in adults in the U.S. and worldwide. Recent work&#xD;
      suggests that dietary intakes may influence sleep. This mechanistic study will test whether&#xD;
      consuming a healthy, Mediterranean diet will improve sleep quality in U.S. adults with poor&#xD;
      sleep and lead to better cardiovascular disease risk profile. Given the relationship between&#xD;
      sleep and cardiovascular health, improving sleep quality through dietary measures could&#xD;
      contribute to improving health in adults.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>Statistician and research technicians involved in data and sample analyses will be blind to intervention.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Score on the Pittsburgh Sleep Quality Index (PSQI)</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <description>The 19 questions which compose this survey assess sleep quality, latency, duration, habitual sleep efficiency, sleep disturbances, medication use and daytime dysfunction. Scores range 0 (minimum) to 21 (maximum) with &gt;5 indicating poor sleep quality so a lower score is a better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Arousal index</measure>
    <time_frame>Change from baseline to 4 weeks</time_frame>
    <description>Arousal index will be actigraphy-derived.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sleep fragmentation index</measure>
    <time_frame>Change from baseline to 4 weeks</time_frame>
    <description>Sleep fragmentation index will be actigraphy-derived.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sleep duration</measure>
    <time_frame>Change from baseline to 4 weeks</time_frame>
    <description>Sleep duration will be actigraphy-derived.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Urinary 6-sulfatoxymelatonin level</measure>
    <time_frame>Change from baseline to 4 weeks</time_frame>
    <description>Urinary 6-sulfatoxymelatonin will be measured by competitive ELISA and urine creatinine by clinical chemistry analyzer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in tryptophan</measure>
    <time_frame>Change from baseline to 4 weeks</time_frame>
    <description>Tryptophan metabolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in kynurenine</measure>
    <time_frame>Change from baseline to 4 weeks</time_frame>
    <description>Tryptophan metabolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in serotonin</measure>
    <time_frame>Change from baseline to 4 weeks</time_frame>
    <description>Neurotransmitter</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Sleep</condition>
  <arm_group>
    <arm_group_label>Mediterranean Diet and then AAD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy participants that are randomized to the MedDiet followed by a 4-week washout and a crossover to the AAD.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Average American Diet (AAD) and then Mediterranean Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy participants that are randomized to AAD followed by a 4-week washout and a crossover to the Mediterranean Diet.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Average American Diet (AAD)</intervention_name>
    <description>Participants will follow specified diet requirements.&#xD;
Macronutrient targets for the AAD will be approximately 35-37% of energy from fat (13.5% from saturated fat), 15% from protein, and 48-50% from carbohydrates (10 g fiber/d for an average 2000 kcal/d diet).</description>
    <arm_group_label>Average American Diet (AAD) and then Mediterranean Diet</arm_group_label>
    <arm_group_label>Mediterranean Diet and then AAD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mediterranean Diet</intervention_name>
    <description>Participants will follow specified diet requirements.&#xD;
Macronutrient targets for the Mediterranean diet will be approximately 40% of energy from fat (8.5% from saturated fat), 20% of energy from protein, and 40% from carbohydrates (40 g fiber/d for an average 2000 kcal/d diet).</description>
    <arm_group_label>Average American Diet (AAD) and then Mediterranean Diet</arm_group_label>
    <arm_group_label>Mediterranean Diet and then AAD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Sleep &gt;6 hours/night&#xD;
&#xD;
          -  Sleep complaints&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Allergies to foods&#xD;
&#xD;
          -  Inability to comply with study procedures&#xD;
&#xD;
          -  Gastrointestinal disorders&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-Pierre St-Onge, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hedda Boege, MS</last_name>
    <phone>(347) 963-8845</phone>
    <email>hlb2156@cumc.columbia.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Columbia University Irving Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hedda Boege, MS</last_name>
      <phone>347-963-8845</phone>
      <email>hlb2156@cumc.columbia.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 26, 2021</study_first_submitted>
  <study_first_submitted_qc>August 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 5, 2021</study_first_posted>
  <last_update_submitted>August 2, 2021</last_update_submitted>
  <last_update_submitted_qc>August 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Marie-Pierre St-Onge</investigator_full_name>
    <investigator_title>Associate Professor of Nutritional Medicine</investigator_title>
  </responsible_party>
  <keyword>Mediterranean diet</keyword>
  <keyword>cardiovascular health</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Will be shared upon request and review by investigators.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Upon publication of main study outcomes.</ipd_time_frame>
    <ipd_access_criteria>Determined upon request.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

